×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share
40762 views

Program

12.30 Introduction
12.32 Overview of devices:
    ○ Veniti stent – Stephen Black
    ○ Wallstent – Olivier Hartung
    ○ IVUS – Peter Neglen
12.47 Case in box n°1: May-Thurner syndrome
Panel discussion
12.57 Case in box n°2: May-Thurner syndrome
Panel discussion
13.07 Acute DVT:
    ○ Goals and history of clot removal strategies – Yves Alimi
    ○ PMT - Stephen Black
13.25 Treatment of chronic lesions:
    ○ Recanalization – Olivier Hartung
13.33 Case in box n°3: Left femoro iliac vein recanalization and stenting
Panel discussion
13.41 Case in box n°4: Left femoro iliac vein recanalization and stenting
Panel discussion
13.55 Conclusion

Educational objectives

  • Diagnostic approach for patients with suspected ilio-femoral vein obstructions
  • Tips and Tricks for venous recanalization in patients with:
    • Acute DVT
    • May Thurner Syndrome
    • Chronic obstructions of the ilio-femoral vein system
  • Stent design, performance and available evidence
  • Value of Intravascular ultrasound (IVUS) for venous recanalizsation

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Angiologists and Interventional Cardiologists) interested and/or specialized in venous interventions
  • Referring physicians of patients with venous disease
Shooting date : 2017-10-13
Last update : 2018-06-26
Stephen Black
London, United Kingdom
Yves Alimi
Marseille, France
13 comments
Join the Discussion
See previous comments (3)
  • Sharif Khashaba K. kindly improve the voice

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Vanessa R. How do you treat venous non thrombotic in stent restenosis

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Gustavo R. In chronic oclusion how often did you see instent stenosis in Iliocaval Wallstent

        • Olivier H. in our experience on 162 patients with a median follow-up of 44 months, primary patency is 70% at 60 months and assisted primary patency 85%

        • Peter N. Using the Wallstent, the cumulative in-stent stenosis rate at 6 years is in non-thrombotic obstructions (NIVL) 1% and in postthrombotic obstructions approximately 10%. In-stent stenosis is then defined as being >50% lumen reduction. It is common to see some in-stent layering of

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Jacobo N. What do you think is the best aproach to the lesion, popliteal or contralateral? Thanks

        • Olivier H. for chronic lesion, i prefer anterograde approach through the femoral or popliteal. Some teams favor internal jugular approach (must always be ready in case of IVC lesions)
          for acute lesions, it depends on the patency of the popliteal vein. If occluded, jugular or controlateral acess

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Maria Fabrizia G. do you use the same strategy in presence of PE?

        • Olivier H. PE does not change the strategy but can make discuss the use of an IVC filter

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • bander A. what is he indications in case of non thrombotic iliac vein lesion ?

        • Olivier H. symptomatic and disabled patients C2-6, pelvic congestion syndrome

        • Peter N. I agree with Olivier, but wants to qualify it slightly. As we pointed out in the discussion, compression of the iliac veins are common in the asymptomatic population and possibly up to 30% have >50% stenosis with no symptoms! So there is a potential risk of overtreatment. In chronic venous disease of the lower limb, treatment of the outflow obstruction is indicated in patients with the C-class in CEAP being marked swelling (C3) and those with skin changes/ulcers (C4-C6). In addition, you have those patients with venous pain without skin changes or varicose veins, which can not be solely explained by the presence of reflux, if any. We use visual analogue scale (VAS) to evaluate that, considering VAS >5 being significant. As Olivier pointed out the symptoms have to affect the patients' quality of life.

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • Sandeep S. When using three stents, why is the middle stent placed last in iliofemoral venous intervention?

        Is there any algorithim to decide on when and not to stent across deep femoral vein?

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        Suggestions

        February 2017
        Honolulu : Wednesday, February 15th 2017 from 01:30am to 03am (GMT+1)
        San Francisco : Wednesday, February 15th 2017 from 03:30am to 05am (GMT+1)
        New York : Wednesday, February 15th 2017 from 06:30am to 08am (GMT+1)
        Buenos Aires : Wednesday, February 15th 2017 from 08:30am to 10am (GMT+1)
        London / Dublin : Wednesday, February 15th 2017 from 11:30am to 01pm (GMT+1)
        Paris / Berlin : Wednesday, February 15th 2017 from 12:30pm to 02pm (GMT+1)
        Istanbul : Wednesday, February 15th 2017 from 01:30pm to 03pm (GMT+1)
        Moscou / Dubaï : Wednesday, February 15th 2017 from 03:30pm to 05pm (GMT+1)
        Bangkok : Wednesday, February 15th 2017 from 06:30pm to 08pm (GMT+1)
        Shanghai : Wednesday, February 15th 2017 from 07:30pm to 09pm (GMT+1)
        Tokyo : Wednesday, February 15th 2017 from 08:30pm to 10pm (GMT+1)
        Sydney : Wednesday, February 15th 2017 from 09:30pm to 11pm (GMT+1)
        Wellington : Wednesday, February 15th 2017 from 11:30pm to 01am (GMT+1)

        New frontiers of complex SFA angioplasties

        Conquering the Complex lesions with step-by-step approach

        Share
        May 2012
        Honolulu : Thursday, May 24th 2012 from 05:59am to 08:13am (GMT+2)
        San Francisco : Thursday, May 24th 2012 from 08:59am to 11:13am (GMT+2)
        New York : Thursday, May 24th 2012 from 11:59am to 02:13pm (GMT+2)
        Buenos Aires : Thursday, May 24th 2012 from 12:59pm to 03:13pm (GMT+2)
        Reykjavik : Thursday, May 24th 2012 from 03:59pm to 06:13pm (GMT+2)
        London / Dublin : Thursday, May 24th 2012 from 04:59pm to 07:13pm (GMT+2)
        Paris / Berlin : Thursday, May 24th 2012 from 05:59pm to 08:13pm (GMT+2)
        Istanbul : Thursday, May 24th 2012 from 06:59pm to 09:13pm (GMT+2)
        Moscou / Dubaï : Thursday, May 24th 2012 from 07:59pm to 10:13pm (GMT+2)
        Bangkok : Thursday, May 24th 2012 from 10:59pm to 01:13am (GMT+2)
        Shanghai : Thursday, May 24th 2012 from 11:59pm to 02:13am (GMT+2)
        Tokyo : Friday, May 25th 2012 from 12:59am to 03:13am (GMT+2)
        Sydney : Friday, May 25th 2012 from 02:59am to 05:13am (GMT+2)
        Wellington : Friday, May 25th 2012 from 04:59am to 07:13am (GMT+2)

        Discover the difference drug elution makes in the SFA with Zilver PTX stents:

        Max Amor, Flavio Airoldi ,Peter Gaines, William Kai,Jorg Tessarek

        Share
        Scroll Up